- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Automatic Translation feature is available on CiNii Labs
- Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Cell Therapy for Ischemic Stroke : Status and Prospects
-
- Horie Nobutaka
- Department of Neurosurgery, Hiroshima University
-
- Mitsuhara Takafumi
- Department of Neurosurgery, Hiroshima University
Bibliographic Information
- Other Title
-
- 虚血性脳血管障害に対する幹細胞治療の多様性
- ―現状と展望―
Search this article
Description
<p> Substantial contributions has made to improve the functional prognosis and reduce mortality rates through advances in medical treatment of ischemic cerebrovascular disease, such as alteplase and tenecteplase during the acute phase, development of cerebrovascular surgery, strengthening of regional cooperation, and standardization of treatment. However, in an aging society, it remains the leading cause of being bedridden due to the influence of underlying diseases, frailty, and the social environment, and is a major factor in rising healthcare costs. The treatment of cerebrovascular disease involves three phases : preventive, acute phase, and chronic phase therapy. Future studies should aim for the development of new treatments for the subacute to chronic phase. Regarding stem cell therapy after cerebral infarction, many basic research reports, clinical trials, and studies are underway or completed worldwide. Here, we review the basic experiments, clinical trials, and studies of stem cell therapy for ischemic cerebrovascular disease and consider future prospects.</p>
Journal
-
- Japanese Journal of Neurosurgery
-
Japanese Journal of Neurosurgery 32 (12), 808-813, 2023
The Japanese Congress of Neurological Surgeons
- Tweet
Details 詳細情報について
-
- CRID
- 1390302315058899328
-
- ISSN
- 21873100
- 0917950X
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- Crossref
-
- Abstract License Flag
- Disallowed